Recent trends in rapid detection of influenza infections by bio and nanobiosensor

Hassanpour, Soodabeh; Baradaran, Behzad; Hejazi, Maryam; Hasanzadeh, Mohammad; Mokhtarzadeh, Ahad; Guárdia, Miguel de la

doi:10.1016/j.trac.2017.11.012

Cited by 61 publications

(34 citation statements)

References 112 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In general, there are several problems with this test, which make it inappropriate in some cases. These problems include false negative, noise reaction made by samples, unspecific reaction because of improper plate washing, time-consuming, the difference between reagent concentration in prepared ELISA kits, being expensive, and the need for expert staff with the skill of triggering immunoassay, working with ELISA reader and other related devices, and calculating the exact amount of antigens or antibodies [ 67 , 68 ]. Taken together, these problems highlight the need for a more efficient alternative approach with a lower sampling rate.…”

Section: Detection Methodsmentioning

confidence: 99%

“…Other commercial biosensors for influenza A and B virus detection are as follows: Quidel, USA; Alere, USA; Directigen EZ Flu A + B, USA; SAS FluAlert A&B, USA; Coris BioConcept, Belgium, Thermo, USA; and OraSure Technologies, Inc., USA. There are also examples of these biosensors for HIV that are now available on the market: Runbio Biotech Co. Ltd., China; Alere, USA; Standard Diagnostics, Inc., Korea; and JAL Innovation, Taiwan [ 68 , 174 ].…”

Section: Summary and Future Outlooksmentioning

confidence: 99%

See 1 more Smart Citation

An Overview on SARS-CoV-2 (COVID-19) and Other Human Coronaviruses and Their Detection Capability via Amplification Assay, Chemical Sensing, Biosensing, Immunosensing, and Clinical Assays

et al. 2020

Self Cite

View full text Add to dashboard Cite

A novel coronavirus of zoonotic origin (SARS-CoV-2) has recently been recognized in patients with acute respiratory disease. COVID-19 causative agent is structurally and genetically similar to SARS and bat SARS-like coronaviruses. The drastic increase in the number of coronavirus and its genome sequence have given us an unprecedented opportunity to perform bioinformatics and genomics analysis on this class of viruses. Clinical tests like PCR and ELISA for rapid detection of this virus are urgently needed for early identification of infected patients. However, these techniques are expensive and not readily available for point-of-care (POC) applications. Currently, lack of any rapid, available, and reliable POC detection method gives rise to the progression of COVID-19 as a horrible global problem. To solve the negative features of clinical investigation, we provide a brief introduction of the general features of coronaviruses and describe various amplification assays, sensing, biosensing, immunosensing, and aptasensing for the determination of various groups of coronaviruses applied as a template for the detection of SARS-CoV-2. All sensing and biosensing techniques developed for the determination of various classes of coronaviruses are useful to recognize the newly immerged coronavirus, i.e., SARS-CoV-2. Also, the introduction of sensing and biosensing methods sheds light on the way of designing a proper screening system to detect the virus at the early stage of infection to tranquilize the speed and vastity of spreading. Among other approaches investigated among molecular approaches and PCR or recognition of viral diseases, LAMP-based methods and LFAs are of great importance for their numerous benefits, which can be helpful to design a universal platform for detection of future emerging pathogenic viruses.

show abstract

Section: Detection Methodsmentioning

confidence: 99%

Section: Summary and Future Outlooksmentioning

confidence: 99%

An Overview on SARS-CoV-2 (COVID-19) and Other Human Coronaviruses and Their Detection Capability via Amplification Assay, Chemical Sensing, Biosensing, Immunosensing, and Clinical Assays

et al. 2020

Self Cite

View full text Add to dashboard Cite

show abstract

“…Biosensors are commonly defined as analytical devices composed of a biological recognition system [92] and a physicochemical transducer [93]. Biosensors have highly selective properties due to possiblity of tailoring the specific interaction of compounds by immobilizing biological recognition elements on the sensor [94]. Typically biosensors comprises three components: a bioreceptor or biological identification component, a signal transducer, and an amplifier [94] (Fig.…”

Section: Nanobiosensormentioning

confidence: 99%

Electrochemical virus detections with nanobiosensors

Kaya

Karadurmuş

Özçelikay

et al. 2020

Nanosensors for Smart Cities

View full text Add to dashboard Cite

“…Different kinds of nanoparticles have demonstrated their potential for the diagnosis, treatment and prevention of viral infections in many applications, especially those nanoparticles with viral material or systems that mimic virus characteristics. This section focuses on the diagnostic techniques developed for the identification and/or quantification of viruses themselves, and more specifically of the viruses that have been more thoroughly investigated and have more relevance [ 71 , 72 , 73 , 74 , 75 , 76 , 77 ].…”

Section: Nanoparticles For Viral Detectionmentioning

confidence: 99%

Nanoparticles for Signaling in Biodiagnosis and Treatment of Infectious Diseases

Colino

Millán

Lanao

2018

IJMS

View full text Add to dashboard Cite

Advances in nanoparticle-based systems constitute a promising research area with important implications for the treatment of bacterial infections, especially against multidrug resistant strains and bacterial biofilms. Nanosystems may be useful for the diagnosis and treatment of viral and fungal infections. Commercial diagnostic tests based on nanosystems are currently available. Different methodologies based on nanoparticles (NPs) have been developed to detect specific agents or to distinguish between Gram-positive and Gram-negative microorganisms. Also, biosensors based on nanoparticles have been applied in viral detection to improve available analytical techniques. Several point-of-care (POC) assays have been proposed that can offer results faster, easier and at lower cost than conventional techniques and can even be used in remote regions for viral diagnosis. Nanoparticles functionalized with specific molecules may modulate pharmacokinetic targeting recognition and increase anti-infective efficacy. Quorum sensing is a stimuli-response chemical communication process correlated with population density that bacteria use to regulate biofilm formation. Disabling it is an emerging approach for combating its pathogenicity. Natural or synthetic inhibitors may act as antibiofilm agents and be useful for treating multi-drug resistant bacteria. Nanostructured materials that interfere with signal molecules involved in biofilm growth have been developed for the control of infections associated with biofilm-associated infections.

show abstract

Recent trends in rapid detection of influenza infections by bio and nanobiosensor

Cited by 61 publications

References 112 publications

An Overview on SARS-CoV-2 (COVID-19) and Other Human Coronaviruses and Their Detection Capability via Amplification Assay, Chemical Sensing, Biosensing, Immunosensing, and Clinical Assays

An Overview on SARS-CoV-2 (COVID-19) and Other Human Coronaviruses and Their Detection Capability via Amplification Assay, Chemical Sensing, Biosensing, Immunosensing, and Clinical Assays

Electrochemical virus detections with nanobiosensors

Nanoparticles for Signaling in Biodiagnosis and Treatment of Infectious Diseases

Contact Info

Product

Resources

About